Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01315782 · ClinicalTrials.gov registry record
Alveolar Dead Space as Predictor of Organ Failure in Severe Sepsis
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Not yet
- Registry status
- 30
- Enrollment target
NCT01315782: Clinical Trial study, sponsored by The University of Texas Health Science Center, Houston.
NCT01315782 is a clinical trial that has not yet begun recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01315782 has not yet begun recruiting, sponsored by The University of Texas Health Science Center, Houston.
- NOT YET RECRUITING
- Registry status
- 30 participants
- Enrollment target
Study Summary
This is an observational study to understand the changes in alveolar dead space in medical critically ill patients with severe infection (severe sepsis) requiring mechanical ventilation and the possibility to predict multi-organ failure. The measurement of alveolar dead space used to require sophisticated equipment and time. New ventilators have microprocessors that allow rapid mathematical calculation with minimal intervention.
Primary Outcome
Multi-oran failure will be accessed by daily laboratory data, heart function by echocardiogram if available, urinary output, vitals and use of vasopressors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-12 |
| Est. Completion | 2026-12 |
What is known before NCT01315782 opens enrollment
NCT01315782 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01315782 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01315782 about?
NCT01315782 is a clinical study titled "Alveolar Dead Space as Predictor of Organ Failure in Severe Sepsis". This is an observational study to understand the changes in alveolar dead space in medical critically ill patients with severe infection (severe sepsis) requiring mechanical ventilation and the possibility to predict multi-organ failure. The measurement of alveolar dead space used to require sophis...
What is the current status of trial NCT01315782?
This trial is currently not yet recruiting. The enrollment target is 30 participants. The study started on 2026-12. Estimated completion is 2026-12.
Who is sponsoring clinical trial NCT01315782?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia